drugset
drugset / Trial / NCT00368056

Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

NCT00368056 ↗

Phase 3 Completed 32 enrolled Sumitomo Pharma America, Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

To assess next day driving ability and psychomotor/memory function following a single night time dose of eszopiclone in insomnia patients.

Timeline

Start
2005-04
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg —

Indications

insomnia